Specifically, we are proposing to codify that in cases where negative or zero ASP data is reported for some, but not all, NDCs of a multiple source drug, we would calculate the payment limit using the positive ASP data reported for the drug, except for the existing carryover policy for multiple source drugs that we would apply when missing data results in a significant change in the ASP payment limit
This is not something to ignore
The most common types of smokeless tobacco in the US are chewing tobacco, plug, twist, snuff, snus, and dissolvable tobacco products
You will find it just as crazy as irresistible
Clarifying these relationships is critical for identifying potential therapeutic targets and developing strategies to mitigate the health impacts of smoking